Overall, while cholesterol may modulate APP amiloydogenic processing and Aβ production, the mitochondrial cholesterol pool emerges as a novel factor in modulating the susceptibility to the noxious effects of toxic Aβ fragments and tau-phosphorylation underlying AD. This evidence concerns the gene MAPT and Alzheimer disease.